Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han J Bonenkamp

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2022
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort studyOlivier J van Not, Melissa M de Meza, Alfons J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
Adjuvant treatment for melanoma in clinical practice - Trial versus realityMelissa M de Meza, Rawa K Ismail, Daan Rauwerdink, et al.
Pageof 3